Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by 3burtc on Mar 10, 2021 7:46am

Big Pharma

Right around the corner? Loos like it.
Comment by Harper75 on Mar 10, 2021 8:16am
We all have been thinking Big Pharma could/would/should be all over this platform for years now.  What's with the "around the corner" comments this morning?  
Comment by 123ABC on Mar 10, 2021 8:19am
  3burt is just a pumper along with crow.
Comment by 3burtc on Mar 10, 2021 8:50am
That's right :)
Comment by MrMugsy on Mar 10, 2021 9:23am
We know Big Pharma started to gain an interest as of August 2020 and we know we had one Big Pharma in the data room around that period. We also know Dan had no interest in entertaining Big Pharma at that time ... not yet ... as he had many other things that needed to happen, complete data collection from P2B, external business studies, IND enabling studies, academic studies and new drug ...more  
Comment by 3burtc on Mar 10, 2021 9:28am
That's exactly what I said.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities